Prognostication of Uveal Melanoma: A Work in Progress.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Uveal Melanoma: 5-Year Update on Incidence, Treatment, and Survival (SEER 1975-2020).Ocular oncology and pathology · 2025
   Article
2. Estrogen Receptor Is Expressed in Uveal Melanoma: A Potential Target for Therapy.Ocular oncology and pathology · 2021
   Article
3. Nation-Wide Trends in Incidence-Based Mortality of Patients with Ocular Melanoma in USA: 2000 to 2018.International journal of general medicine · 2021
   Article
4. Uveal Melanoma: 5-Year Update on Incidence, Treatment, and Survival (SEER 1973-2013).Ocular oncology and pathology · 2018
   Article
5. Comparison of Gene Expression Profiling and Chromosome 3 Analysis by Fluorescent in situ Hybridization and Multiplex Ligation Probe Amplification in Fine-Needle Aspiration Biopsy Specimens of Uveal Melanoma.Ocular oncology and pathology · 2017
   Article
6. Prognostication for Uveal Melanoma: Are Two Tests Better than One?Ocular oncology and pathology · 2017
   Article
7. PRiMeUM: A Model for Predicting Risk of Metastasis in Uveal Melanoma.Investigative ophthalmology & visual science · 2017
   Article

Corrections and comments

• Commented on by
  Failure to Disclose Conflicts of Interest.2016
• Comment on
  Driver Mutations in Uveal Melanoma: Associations With Gene Expression Profile and Patient Outcomes.2016
• Comment on
  Prognostic Implications of Tumor Diameter in Association With Gene Expression Profile for Uveal Melanoma.2016
• Erratum issued
  Failure to Disclose Conflicts of Interest.2016

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as